milk thistle extract (silymarin)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
milk thistle extract (silymarin) — no detected effect on serious adverse event incidence
Evidence strength: very limited.FindingNull result“The evidence suggests that silymarin monotherapy versus no intervention or placebo may result in little to no difference in serious adverse events (Peto OR 1.55, 95% CI 0.26 to 9.28; 4 trials, 304 participants; low-certainty evidence).”
Quoted verbatim from Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.. - Study
- meta-analysis
- Participants
- 304
- Population
- Adults with metabolic dysfunction-associated steatotic liver disease; silymarin monotherapy versus no intervention or placebo
Effect 1.55 odds ratio, 95% CI 0.26 to 9.28
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.2025PMID:4055256910.1002/14651858.CD015524.pub2Permalink
To cite this finding: https://catalystproject.ai/e/01M5SS6VCSV07NJHPK6GS96WJV